GSA Capital Partners’s Biodesix BDSX Stock Holding History

GSA Capital Partners’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$571K	Sell	39,406 -25,077	-39%	-$311K	0.04%	828
2025 Q4	$438K	Buy	64,483 +16,141	+33%	+$119K	0.04%	909
2025 Q3	$365K	Buy	48,342 +1,772	+4%	+$13.6K	0.03%	1078
2025 Q2	$263K	Buy	46,570 +44,903	+2,694%	+$363K	0.02%	1340
2025 Q1	$21K	Buy	+1,667	New	+$32K	﹤0.01%	1583

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

GSA Capital Partners's BDSX Position: Q1 2026 in Review

GSA Capital Partners reduced its Biodesix (BDSX) stake by 39% in Q1 2026, selling an estimated $311K and leaving 39,406 shares worth $571K. The position accounts for 0.04% of the portfolio, ranked #828.

GSA Capital Partners first reported a position in BDSX in Q1 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

GSA Capital Partners held 39,406 shares of Biodesix worth $571K as of Q1 2026.
GSA Capital Partners sold 25,077 Biodesix shares in Q1 2026, an estimated $311K.
Biodesix made up 0.04% of GSA Capital Partners's portfolio in Q1 2026, its #828 holding.
GSA Capital Partners first reported a position in Biodesix in Q1 2025 and has held it in 5 quarters since.
40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.